Selected article for: "admission treatment and logistic regression"
Author: Fervers, Philipp; Kottlors, Jonathan; Zopfs, David; Bremm, Johannes; Maintz, David; Safarov, Orkhan; Tritt, Stephanie; Abdullayev, Nuran; Persigehl, Thorsten
Title: Calcification of the thoracic aorta on low-dose chest CT predicts severe COVID-19
  • Cord-id: isev63tg
  • Document date: 2020_12_23
    • ID: isev63tg
    Snippet: BACKGROUND: Cardiovascular comorbidity anticipates poor prognosis of SARS-CoV-2 disease (COVID-19) and correlates with the systemic atherosclerotic transformation of the arterial vessels. The amount of aortic wall calcification (AWC) can be estimated on low-dose chest CT. We suggest quantification of AWC on the low-dose chest CT, which is initially performed for the diagnosis of COVID-19, to screen for patients at risk of severe COVID-19. METHODS: Seventy consecutive patients (46 in center 1, 24
    Document: BACKGROUND: Cardiovascular comorbidity anticipates poor prognosis of SARS-CoV-2 disease (COVID-19) and correlates with the systemic atherosclerotic transformation of the arterial vessels. The amount of aortic wall calcification (AWC) can be estimated on low-dose chest CT. We suggest quantification of AWC on the low-dose chest CT, which is initially performed for the diagnosis of COVID-19, to screen for patients at risk of severe COVID-19. METHODS: Seventy consecutive patients (46 in center 1, 24 in center 2) with parallel low-dose chest CT and positive RT-PCR for SARS-CoV-2 were included in our multi-center, multi-vendor study. The outcome was rated moderate (no hospitalization, hospitalization) and severe (ICU, tracheal intubation, death), the latter implying a requirement for intensive care treatment. The amount of AWC was quantified with the CT vendor's software. RESULTS: Of 70 included patients, 38 developed a moderate, and 32 a severe COVID-19. The average volume of AWC was significantly higher throughout the subgroup with severe COVID-19, when compared to moderate cases (771.7 mm(3) (Q1 = 49.8 mm(3), Q3 = 3065.5 mm(3)) vs. 0 mm(3) (Q1 = 0 mm(3), Q3 = 57.3 mm(3))). Within multivariate regression analysis, including AWC, patient age and sex, as well as a cardiovascular comorbidity score, the volume of AWC was the only significant regressor for severe COVID-19 (p = 0.004). For AWC > 3000 mm(3), the logistic regression predicts risk for a severe progression of 0.78. If there are no visually detectable AWC risk for severe progression is 0.13, only. CONCLUSION: AWC seems to be an independent biomarker for the prediction of severe progression and intensive care treatment of COVID-19 already at the time of patient admission to the hospital; verification in a larger multi-center, multi-vendor study is desired.

    Search related documents:
    Co phrase search for related documents
    • accurate early and logistic regression model: 1, 2
    • accurate early and lung disease: 1, 2, 3, 4, 5, 6
    • accurate early and lung involvement: 1
    • accurate early detection and logistic regression: 1, 2, 3
    • accurate early detection and lung disease: 1
    • ace inhibitor and logistic regression: 1, 2, 3, 4, 5, 6, 7
    • ace inhibitor and logistic regression model: 1, 2
    • ace inhibitor and lung disease: 1
    • ace inhibitor and lung tissue: 1, 2, 3, 4
    • active smoking and additional point: 1
    • active smoking and logistic regression: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14
    • active smoking and logistic regression model: 1
    • active smoking and lung involvement: 1, 2
    • active smoking hyperlipidemia and logistic regression: 1
    • active smoking hyperlipidemia and lung involvement: 1
    • additional point and logistic regression: 1, 2, 3, 4, 5